MEDIROM Healthcare Technologies
MRM
1 hedge funds and large institutions have $13K invested in MEDIROM Healthcare Technologies in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0.28% less ownership
Funds ownership: 0.32% → 0.04% (-0.28%)
75% less funds holding
Funds holding: 4 → 1 (-3)
89% less capital invested
Capital invested by funds: $116K → $13K (-$103K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$69.5K |
| 2 |
Morgan Stanley
New York
|
-$14K |
| 3 |
JP Morgan Chase
New York
|
-$12K |
| 4 |
Citigroup
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $13K | -$69.5K | -9,812 | -82% |
|
|
2
Morgan Stanley
New York
| – | -$14K | -1,900 | Closed |
|
|
3
JP Morgan Chase
New York
| – | -$12K | -1,600 | Closed |
|
|
4
Citigroup
New York
| – | -$2K | -297 | Closed |
|
MRM Hedge Fund Activity: Q2 2022 in Review
1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q2 2022, worth a combined $13K — down 89% from $116K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MRM and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $69.5K.
- 1 institutional investor held MEDIROM Healthcare Technologies (MRM) as of Q2 2022, down from 4 in Q1 2022.
- Funds reported $13K of MEDIROM Healthcare Technologies stock for Q2 2022, down 89% quarter-over-quarter.
- 0 funds opened new MEDIROM Healthcare Technologies positions in Q2 2022 and 3 closed out, a net change of -3 holders.
- The largest MEDIROM Healthcare Technologies seller in Q2 2022 was UBS Group, an estimated $69.5K sold.
Based on aggregated 13F filings for Q2 2022.